Frequently Asked Questions
Common Questions About Using ICD-10 Code F18.97 for Inhalant use, unsp with inhalant-induced persisting dementia
What are the long-term effects of inhalant use?
Long-term inhalant use can lead to persistent cognitive deficits, neurological damage, and behavioral changes. Patients may experience memory loss, attention deficits, and mood disorders, necessitating comprehensive treatment and support.
How is inhalant-induced dementia diagnosed?
Diagnosis involves a thorough patient history of inhalant use, cognitive assessments, and ruling out other causes of dementia. Clinicians should document symptoms and functional impairments to support the diagnosis.
What treatment options are available for inhalant-induced dementia?
Treatment focuses on cognitive rehabilitation, psychosocial support, and addressing any co-occurring mental health issues. Family involvement and education about the effects of inhalant use are also crucial.
Is hospitalization necessary for patients with inhalant-induced dementia?
Hospitalization may be required for severe cases, particularly if there are acute psychiatric symptoms or significant cognitive decline. A comprehensive treatment plan should be developed in such cases.
